# Effectiveness of Systane PRO for Mild to Moderate Dry Eye Disease

> **NCT07639034** · PHASE4 · COMPLETED · sponsor: **Gordon Schanzlin New Vision** · enrollment: 33 (actual)

## Conditions studied

- Dry Eye Disease (DED)

## Interventions

- **DRUG:** Systane Pro Topical Ophthalmic

## Key facts

- **NCT ID:** NCT07639034
- **Lead sponsor:** Gordon Schanzlin New Vision
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2025-11-01
- **Primary completion:** 2026-02-01
- **Final completion:** 2026-02-01
- **Target enrollment:** 33 (ACTUAL)
- **Last updated:** 2026-06-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07639034

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07639034, "Effectiveness of Systane PRO for Mild to Moderate Dry Eye Disease". Retrieved via MORVS 2026-10-21 from https://api.morvs.ai/clinical/NCT07639034. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*